Growth Metrics

Idexx Laboratories (IDXX) Short-term Investments (2016 - 2017)

Idexx Laboratories has reported Short-term Investments over the past 6 years, most recently at $284.3 million for Q4 2017.

  • For Q4 2017, Short-term Investments rose 19.96% year-over-year to $284.3 million; the TTM value through Dec 2017 reached $284.3 million, up 19.96%, while the annual FY2017 figure was $284.3 million, 19.96% up from the prior year.
  • Short-term Investments for Q4 2017 was $284.3 million at Idexx Laboratories, roughly flat from $285.1 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $285.1 million in Q3 2017 and troughed at $453000.0 in Q1 2014.
  • A 5-year average of $145.5 million and a median of $208.4 million in 2015 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: tumbled 90.07% in 2014 and later skyrocketed 30631.79% in 2015.
  • Year by year, Short-term Investments stood at $1.1 million in 2013, then skyrocketed by 910.47% to $10.9 million in 2014, then skyrocketed by 1859.01% to $213.6 million in 2015, then increased by 10.94% to $236.9 million in 2016, then rose by 19.96% to $284.3 million in 2017.
  • Business Quant data shows Short-term Investments for IDXX at $284.3 million in Q4 2017, $285.1 million in Q3 2017, and $256.9 million in Q2 2017.